Impact of tumor-associated macrophages and BRAFV600E mutation on clinical outcomes in patients with various thyroid cancers.
Jae Won ChoWon Woong KimYu Mi LeeMin Ji JeonWon Gu KimDong Eun SongYangsoon ParkKi-Wook ChungSuck Joon HongTae-Yon SungPublished in: Head & neck (2019)
CD68 positivity was more frequent in advanced and aggressive thyroid cancer types such as PDTC/ATC.
Keyphrases